Efficacy and safety exposure-response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study Article

cited authors

  • T'jollyn, Huybrecht; Ackaert, Oliver; Chien, Caly; Lopez-Gitlitz, Angela; McCarthy, Sharon; Ruixo, Carlos Perez; Karsh, Lawrence; Chi, Kim; Chowdhury, Simon; Ruixo, Juan-Jose Perez; Agarwal, Neeraj

Publication Date

  • April 2, 2022

webpage

published in

category

keywords

  • Apalutamide
  • Exposure-response
  • Metastatic
  • Prostate cancer

start page

  • 629

end page

  • 641

volume

  • 89

issue

  • 5